Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8478910rdf:typepubmed:Citationlld:pubmed
pubmed-article:8478910lifeskim:mentionsumls-concept:C0001041lld:lifeskim
pubmed-article:8478910lifeskim:mentionsumls-concept:C0205378lld:lifeskim
pubmed-article:8478910lifeskim:mentionsumls-concept:C1698986lld:lifeskim
pubmed-article:8478910lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:8478910pubmed:issue8lld:pubmed
pubmed-article:8478910pubmed:dateCreated1993-5-24lld:pubmed
pubmed-article:8478910pubmed:abstractTextIntroduction of a nitrogen atom into the cyclohexane ring of 2-(4-phenylpiperidinyl)cyclohexanol (vesamicol, AH5183) yielded two positional isomers, 5-azavesamicol (5, prezamicol) and 4-azavesamicol (6, trozamicol). As inhibitors of vesicular acetylcholine transport, 5 and 6 were found to be 147 and 85 times less potent than vesamicol. N-Benzoylation of 5 (to yield 9a) increased the potency 3-fold. In contrast, 10a, a compound derived from N-benzoylation of 6, was 50 times more potent than the latter and almost equipotent with vesamicol, thereby suggesting a preference for the 4-azavesamicol series. Although (-)-vesamicol is more potent than its dextrorotary isomer, (+)-10a was found to be 3 times more potent than (-)-10a, suggesting a reversal of the sign of rotation in the azavesamicol series. Reduction of 9a and 10a (to yield the corresponding N-benzyl derivatives 11a and 12a) increased potency 20- and 2-fold, respectively, indicating a preference for a basic nitrogen. The reaction of 5 or 6 with substituted benzyl halides yielded several potent inhibitors of vesicular acetylcholine transport, including N-(p-fluorobenzyl)trozamicol, 12d, which is twice as potent as vesamicol. Thus the introduction of a nitrogen atom into the cyclohexane ring of vesamicol provides opportunities for developing a new class of anticholinergic agents.lld:pubmed
pubmed-article:8478910pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:languageenglld:pubmed
pubmed-article:8478910pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:citationSubsetIMlld:pubmed
pubmed-article:8478910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8478910pubmed:statusMEDLINElld:pubmed
pubmed-article:8478910pubmed:monthAprlld:pubmed
pubmed-article:8478910pubmed:issn0022-2623lld:pubmed
pubmed-article:8478910pubmed:authorpubmed-author:ParsonsS MSMlld:pubmed
pubmed-article:8478910pubmed:authorpubmed-author:BahMMlld:pubmed
pubmed-article:8478910pubmed:authorpubmed-author:KhareAAlld:pubmed
pubmed-article:8478910pubmed:authorpubmed-author:EfangeS MSMlld:pubmed
pubmed-article:8478910pubmed:authorpubmed-author:MetzenthinTTlld:pubmed
pubmed-article:8478910pubmed:issnTypePrintlld:pubmed
pubmed-article:8478910pubmed:day16lld:pubmed
pubmed-article:8478910pubmed:volume36lld:pubmed
pubmed-article:8478910pubmed:ownerNLMlld:pubmed
pubmed-article:8478910pubmed:authorsCompleteYlld:pubmed
pubmed-article:8478910pubmed:pagination985-9lld:pubmed
pubmed-article:8478910pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:meshHeadingpubmed-meshheading:8478910-...lld:pubmed
pubmed-article:8478910pubmed:year1993lld:pubmed
pubmed-article:8478910pubmed:articleTitleNonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage.lld:pubmed
pubmed-article:8478910pubmed:affiliationDepartment of Radiology, University of Minnesota, Minneapolis 55455.lld:pubmed
pubmed-article:8478910pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8478910pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8478910pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8478910lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8478910lld:pubmed